Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05184556 · ClinicalTrials.gov registry record · NA

Project HOME: Home-Based Treatment Options and Mechanisms for Eating Disorders

A NA study of Anorexia Nervosa and Eating Disorders, sponsored by University of Pittsburgh.

Active
Registry status
NA
Development phase
77
Enrollment target
2
Study locations

NCT05184556: Active NA study of Anorexia Nervosa and Eating Disorders, sponsored by University of Pittsburgh.

NCT05184556 is a NA study of Anorexia Nervosa and Eating Disorders that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 77 participants, below the 948-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05184556, a NA study of Anorexia Nervosa and Eating Disorders, is active but no longer recruiting, sponsored by University of Pittsburgh.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
77 participants
Enrollment target
2
Study locations

Study Summary

This randomized, controlled effectiveness trial will assess outcomes, implementation, and mechanisms of two psychological treatments for adolescent anorexia nervosa (AN) delivered in the home setting, in the context of community-based mental health. Adolescents with AN-spectrum disorders (n=50) and their caregivers will be randomly assigned to either family-based treatment or integrated family therapy delivered in the home. Caregivers and adolescents will provide data on weight, eating, and putative treatment mechanisms, including caregiver self-efficacy, adolescent distress, and generalizability of treatment skills. Treatment feasibility, acceptability, and appropriateness will be measured among providers and participating families. The proposed study has clear potential to advance scientific and clinical understanding of the real-world effectiveness of psychological treatments for AN, including whether adapting them for the home setting may improve accessibility and effects on treatment outcome

Primary Outcome

Adolescents will have their height and weight measured to calculate BMI percentile using CDC growth charts and accompanying procedures.

Interventions

  • BEHAVIORAL Family-based treatment (FBT)
  • BEHAVIORAL Integrative family therapy

Study Locations (2)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Rhode Island

  • Gateway Healthcare - Pawtucket

Trial Details

FieldValue
Enrollment Target 77 participants
Start Date 2022-08-01
Est. Completion 2026-04-30
Phase NA
University of Pittsburgh

1,238 total trials

What the registry record for NCT05184556 still lists

NCT05184556 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 948-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (92% lower).

The record links to 2 conditions, with Anorexia Nervosa appearing as the primary indexed condition, and to 2 interventions - of which Family-based treatment (FBT) is the first listed.

NCT05184556 reports a single indexed study location in Pennsylvania, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT05184556 about?

NCT05184556 is a clinical study titled "Project HOME: Home-Based Treatment Options and Mechanisms for Eating Disorders". This randomized, controlled effectiveness trial will assess outcomes, implementation, and mechanisms of two psychological treatments for adolescent anorexia nervosa (AN) delivered in the home setting, in the context of community-based mental health. Adolescents with AN-spectrum disorders (n=50) and ...

What is the current status of trial NCT05184556?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 77 participants. The study started on 2022-08-01. Estimated completion is 2026-04-30.

What conditions does trial NCT05184556 study?

This clinical trial studies the following conditions: Anorexia Nervosa, Eating Disorders.

What interventions are being tested in trial NCT05184556?

The interventions under investigation include: Family-based treatment (FBT) (BEHAVIORAL), Integrative family therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT05184556?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05184556 being conducted?

This trial has 2 study locations across Pennsylvania, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anorexia Nervosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05184556's enrollment target sits among peer trials

77 16th of 43 higher than 28 of 43 other Anorexia Nervosa trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anorexia Nervosa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02127398 · 77 participants · Phase 2

    Stool Transplants to Treat Refractory Clostridium Difficile Colitis

  • NCT04159103 · 77 participants · Phase 1

    Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

  • NCT04683003 · 77 participants · Phase 3

    A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

  • NCT05004116 · 77 participants · Phase 1

    A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05184556, the US trial registry maintained by the National Library of Medicine. NCT05184556 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.